BENEFICIAL EFFECT OF VITAMIN D ON HIGH-FAT DIET-INDUCED OBESITY IN WISTAR RATS
Abstract
ABSTRACT
Objectives: The aim of the present study was to investigate the antiobesity effects of vitamin D (VD) on high-fat diet (HFD)-induced obesity in Wistar
rats.
Methods: In the present study, male Wistar rats were selected after 4 weeks feeding of HFD and then treated with different doses of VD
(2.5-10 mcg/kg/day, p.o.o.d.) for 6 weeks along with HFD. Orlistat (30 mg/kg/day, p.o.o.d.), which is a lipase inhibitor a standard drug for obesity
was used as a standard control in the present study. The effects of these treatments on body weight parameters, feed intake (Kcal), weight and size of
fat pads, levels of serum glucose, triglycerides (TGs), total cholesterol (TC), high-density lipoproteins (HDL), and low-density lipoprotein (LDL) were
analyzed.
Results: Treatment with VD (2.5-10 mcg/kg/day, p.o.o.d.) produced significant dose-dependent decrease (p<0.05) in body weight parameters, feed
intake (Kcal), weight and size of fat pads, levels of serum glucose, TGs, TC, and LDL as compared to HFD group. Moreover, the level of serum HDLs was
increased as compared to HFD group.
Conclusions: VD treatment ameliorated established obesity and associated biochemical consequences. The results suggest that administration of VD
can inhibit the development of obesity and associated metabolic consequences in HFD-induced obesity.
Keywords: Obesity, Vitamin D, High-fat diet.
Downloads
References
REFERANCES:
Flegal KM, Graubard BI, Williamson DF et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861–1867.
Khorassani FE, Misher A, Garris S.Past and present of anti-obesity agents: focus on monoamine modulators. Am J Health Syst Pharm 2015;72:697-706.
Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004;80:1706.
Kota SK, Kota SK, Jammula S et al. Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study. Indian J Endocrinol Metab 2011;15:S395–S401.
Creely SJ, McTernan PG, Kusminski CM et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E740–E747.
Kim SJ, Choi Y, Choi YH et al. Obesity activates toll-like receptor mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem 2012;23:113–122.
Dickie L, Church L, Coulthard L et al. Vitamin D3 downregulates intracellular toll-like receptor 9 expression and toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatol 2010;48:1466–1471.
Xiang W, Kong J, Chen S et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Phys Endocrinol Met 2005;288:E125–E132.
Vaidya A, Sun B, Larson C et al. Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab 2012: 97:2456–2465.
Huebbe P, Nebel A, Siegert S. et al. APOE ε4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011;25:3262–3270.
Jouni ZE, McNamara DJ. Lipoprotein receptors of HL-60 macrophages. Effect of differentiation with tetramyristicphorbol acetate and 1, 25- dihydroxyvitamin D3. Arterioscler Thromb 1991;11:995–1006.
Bhatia M, Kirkland JB, Mecking-Gill KA. Modulation of poly (ADP-ribose) polymerase during neurophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leakaemia cells. Biochemical Journal 1995;308:131–137.
Shen M, Yen A. Nicotinamide cooperates with retinoic acid and 1, 25-dihydroxyvitamin D3 to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells. Oncology 2009;76:91–100.
Mabley JG, Wallace R, Pacher P et al. Inhibition of poly (adenosine diphosphate-ribose) polymerase by the active form of vitamin D. International Journal of Molecular Medicine 2007;9:947–952.
Bouloumie A, Sengenes C, Portolan G.et al. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Endocrinol Metab 2001;15: S395–S401.
Garvin P, Nilsson L, Carstensen J et al. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS One 2008;3: e1774.
Laimer M, Kaser S, Kranebitte M et al. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes 2005;29:498–501.
Ravid A, Rubinstein E, Gamady A, et al. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 2002;173:525–532.
Zhang Y, Leung DY,Richers BN et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012;188:2127–2135.
Aparna R, Subhashini J, Roy KR, et al. Selective inhibition of cyclooxygenase-2 (COX-2) by 1 α,25-dihydroxy- 16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog. J Cell Biochem 2008;104: 1832–1842.
Moreno J, Krishnan AV, Swami S, et al. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Research 2005;65:7917–7925.
Bao BY, Ting HJ, Hsu JW, et al. Protective role of 1α, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. Int J Cancer 2008;122: 2699–2706.
Somjen D, Katzburg S, Grafi-Cohen M, et al. Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line. J Steroid Biochem Mol Biol 2011;123:85–89.
Chang JM, Kuo MC, Kuo HT, et al. 1-α, 25- Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW264.7 cells. J Lab Clin Med 2004;143:14–22.
Equils O, Naiki Y, Shapiro AM, et al. 1,25- Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells. ClinExpImmunol 2006;143:58–64.
Srinivasan K. Combination of high- fat diet-fed and low-dose streptozotocin-treated rat; A model for type 2 diabetes and pharmacological screening.Pharmacol Res 2005;52:313-320.
Malik. ZA and Sharma P.L. An ethanolic extract from licorice (glycyrrhizaglabra) exhibits anti-obesity effects by decreasing dietary fat absorption in a high fat diet-induced obesity rat model. IJPSR 2011;2: 3010-3018
Bernardis LL et al.Nutritional studies in the weanling rat with normophagic hypothalamic obesity. J. Nutr 1982;112: 1441-1455.
Novellie LB, Diniz YS, Galhardi CM et al. Anthropometrical parameters and markers of obesity in rats. Lab Animals 2007;41:111-119.
Storlien LH, James DE, Burleigh KM et al. Fat feeding causes wide spread in vivo insulin resistance, decreased energy expenditure and obesity in rats. Am J Physio 1986;251:E576-E586.
Woods SC et al.Controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003;133:1081-7.
Ikemoto S et al.High fat diet-induced hyperglycemia: Prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc. Natl. Acad. Sci USA 1995;92:3096-3099.
Oldham S. High Fat Diet Induced Obesity and Nutrient sensing TOR Signaling. Trends Endocrinol Met 2011;22:45-52.
Bloom SR,Kuhajda FP, Laher I, et al. The obesity epidemic: pharmacological challenges.Mol Interv 2008;8: 82–98.
Andersen T, Mcnair P, Fogh-Andersen H, et al. Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism 1985;35:147-51.
Bell NH, Epstein S, Greene A, et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985;76:370-373.
Bell NH, Epstein S, Greene A, et al. Evidence of a probable role for 25-hydroxy vitamin D in the regulation of common calcium metabolism. J Bone Miner Res 1988; 3:489-95.
Liel Y, Ulmer E, Shary J, et al. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199-201.
Saliba W, Barnett-Griness O, Rennert G. The relationship between obesity and the increase in serum 25(OH) D levels in response to vitamin D supplementation. Osteoporos Int. 2013;24:1447-54.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.